A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA

Table 5 Summary of lotilaner tablet acceptance

Study visit	Number of cats^a	Tablet(s) accepted voluntarily (%)^b,c	Tablet(s) Accepted Placed in Mouth (%)^b,d	Tablet(s) successfully dosed by pet owner (%)^b	Tablet(s) could not be administered by pet owner (%)^b,e
Day 0	225	48.0	52.0	100	0.0
Day 30	213	49.3	50.2	99.5	0.5
Day 60	210	43.3	55.7	99	1.0
All doses	648	46.9	52.6	99.5	0.5

^aOnly cats with data on how the tablet was accepted were included in the number of cats available
^bThe denominator for all percentages calculated is the number of cats in the respective row of the table
^cVoluntary acceptance refers to tablets consumed unaided (by the hand, on the floor or empty food bowl) or with the addition of food
^dPlaced in mouth refers to a cat that consumed the tablet(s) after tablet was placed at the back of the mouth
^eRefers to doses which could not be administered by the pet owner. Two cats were successfully redosed by clinic study staff

ISSN: 1756-3305